E8Efficacy of ceritinib administered to patients with crizotinib-refractory, ALK-positive, advanced NSCLC within the Italian compassionate use program
Giulio Metro,Antonio Passaro,G. Lo Russo,Laura Bonanno,Raffaele Giusti,Vanesa Gregorc,Enrica Capelletto,Olga Martelli,Fabiana Letizia Cecere,D. Giannarelli,Andrea Luciani,Alessandra Bearz,Alessandro Tuzi,Vieri Scotti,Giuseppe Tonini,Domenico Galetta,A M Carta,H. Soto Parra,Alessandro Morabito,Rita Chiari ANNALS OF ONCOLOGY（2017）
AI 理解论文
溯源树
样例
